Fresenius SE & Co. KGaA (ETR:FRE)
42.52
+0.75 (1.80%)
May 15, 2025, 5:35 PM CET
Fresenius SE & Co. KGaA Revenue
Fresenius SE & Co. KGaA had revenue of 5.65B EUR in the quarter ending March 31, 2025, with 5.63% growth. This brings the company's revenue in the last twelve months to 22.13B, up 4.61% year-over-year. In the year 2024, Fresenius SE & Co. KGaA had annual revenue of 21.83B with 3.64% growth.
Revenue (ttm)
22.13B
Revenue Growth
+4.61%
P/S Ratio
1.06
Revenue / Employee
126.33K
Employees
176,486
Market Cap
23.53B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 21.83B | 766.00M | 3.64% |
Dec 31, 2023 | 21.07B | -465.00M | -2.16% |
Dec 31, 2022 | 21.53B | -15.99B | -42.61% |
Dec 31, 2021 | 37.52B | 1.24B | 3.43% |
Dec 31, 2020 | 36.28B | 868.00M | 2.45% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 23.14B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Carl Zeiss Meditec AG | 2.17B |
Fielmann Group AG | 2.33B |
SCHOTT Pharma AG & Co. KGaA | 954.68M |
Fresenius SE & Co. KGaA News
- 7 days ago - Fresenius medical care outlines 2025 operating income growth targets amid strategic transformations - Seeking Alpha
- 7 days ago - Fresenius SE & Co. KGaA 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 7 days ago - Fresenius SE & Co. KGaA (FSNUF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Fresenius SE & Co. KGaA reports Q1 results - Seeking Alpha
- 8 days ago - Fresenius posts profit beat in first quarter, confirms outlook - Reuters
- 18 days ago - Fresenius: Holding On For Longer-Term Growth Driven By Demand In Kidney Care Segment - Seeking Alpha
- 5 weeks ago - EQS-AGM: Fresenius SE & Co. KGaA: Announcement of the Convening of the General Meeting in Frankfurt am Main on 23.05.2025 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution - Wallstreet:Online
- 5 weeks ago - Pacira Settles Patent Dispute Over Exparel With Fresenius, Delays Pain Med' Generics Entry Until 2030, Stock Jumps - Benzinga